Species- and cell type-specific interactions between CD47 and human SIRPalpha. - Wikidata - wikimedia - TriplyDB

Species- and cell type-specific interactions between CD47 and human SIRPalpha.

Species- and cell type-specific interactions between CD47 and human SIRPalpha.

http://www.wikidata.org/entity/Q42064991

about

CD47: A Cell Surface Glycoprotein Which Regulates Multiple Functions of Hematopoietic Cells in Health and Disease Signal regulatory protein alpha (SIRPalpha)/CD47 interaction and function Therapeutic opportunities for targeting the ubiquitous cell surface receptor CD47 Kidney xenotransplantation Immune modulation in xenotransplantation Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigm Splenic Dendritic Cells Survey Red Blood Cells for Missing Self-CD47 to Trigger Adaptive Immune Responses.CD47 is expressed at normal levels in patients with autoimmune haemolytic anaemia and/or immune thrombocytopenia.Using LongSAGE to Detect Biomarkers of Cervical Cancer Potentially Amenable to Optical Contrast Agent Labelling.Role for CD47-SIRPalpha signaling in xenograft rejection by macrophages.The role of cis dimerization of signal regulatory protein alpha (SIRPalpha) in binding to CD47 Expression of recipient CD47 on rat insulinoma cell xenografts prevents macrophage-mediated rejection through SIRPα inhibitory signaling in mice.Cell rigidity and shape override CD47's "self"-signaling in phagocytosis by hyperactivating myosin-II.Novel CD47: SIRPα dependent mechanism for the activation of STAT3 in antigen-presenting cell.The effect of CD47 modified polymer surfaces on inflammatory cell attachment and activation.The use of the ex vivo Chandler Loop Apparatus to assess the biocompatibility of modified polymeric blood conduits.Functional CD47/signal regulatory protein alpha (SIRP(alpha)) interaction is required for optimal human T- and natural killer- (NK) cell homeostasis in vivo.Human cancer growth and therapy in immunodeficient mouse models.Expression of mouse CD47 on human cancer cells profoundly increases tumor metastasis in murine models.Macrophage engulfment of a cell or nanoparticle is regulated by unavoidable opsonization, a species-specific 'Marker of Self' CD47, and target physical properties.Diminished adhesion and activation of platelets and neutrophils with CD47 functionalized blood contacting surfaces.Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma Cell Adhesion on Amyloid Fibrils Lacking Integrin Recognition Motif.CD47 signaling pathways controlling cellular differentiation and responses to stress.Naturally occurring anti-band 3 antibodies in clearance of senescent and oxidatively stressed human red blood cells.Differential interactions of thrombospondin-1, -2, and -4 with CD47 and effects on cGMP signaling and ischemic injury responses.Anti-CRLF2 Antibody-Armored Biodegradable Nanoparticles for Childhood B-ALL SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells.The use of CD47-modified biomaterials to mitigate the immune response.Intravenous delivery of siRNA targeting CD47 effectively inhibits melanoma tumor growth and lung metastasis.Enhanced Reconstitution of Human Erythropoiesis and Thrombopoiesis in an Immunodeficient Mouse Model with Kit(Wv) Mutations.CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells.Targeting CD47: the achievements and concerns of current studies on cancer immunotherapy.CD47 in xenograft rejection and tolerance induction.Monoclonal antibody therapy directed against human acute myeloid leukemia stem cells.CD47: a new player in phagocytosis and xenograft rejection.Novel methods of targeted drug delivery: the potential of multifunctional nanoparticles.The CD47-SIRPα signalling system: its physiological roles and therapeutic application.Addressing the Inflammatory Response to Clinically Relevant Polymers by Manipulating the Host Response Using ITIM Domain-Containing Receptors.Minimal "Self" peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles

P2860

Q21284814-89E771DD-4286-4459-B7BB-8C31ADACAE16 Q24598828-A2118C19-C8F0-4EB0-AE3E-1BBB85192CE9 Q24627155-53FF3DDC-172B-4822-979B-231E53B25170 Q26822638-F901E895-8033-4F1B-9B3D-F7446301F98B Q26826905-22D1A910-56D6-47AA-86B3-F8C2DC3BAE39 Q27026630-764F9173-A043-48C4-BC0D-5777F5A7F741 Q30670402-24B81C88-8CC0-41A2-9469-3FC68B8E3F37 Q33373564-1E34937F-F220-4CF7-8E1C-E8D857DB8C65 Q33491567-ABC44049-C426-4F66-9845-444812045934 Q34002961-C4E7E139-416B-41DC-9FA8-757A1F48491A Q34351985-06F1F2AC-7A4A-4351-AA42-3B97231B604B Q34614958-93C27337-4FBF-41F5-B7B9-D784C1A64E64 Q34974078-EA62DADF-C2EB-4123-BBDC-98F1D87B27FF Q35000908-A33B3425-3EA5-4AC9-A98C-26E2D5238FFE Q35024822-E0D7DCF9-E028-437C-89EA-8720B1E650C4 Q35076985-45384996-8BA6-47DC-93D4-48D0D451A7CD Q35164726-2FC8459B-9ABF-4F3F-84F1-B26DF7D214C6 Q35545282-2A575F1F-7EE6-4495-BE09-FB10A5312958 Q35870447-1193FD11-3F67-4BC1-B81C-F656A17E4B44 Q36005980-C825E7E9-851C-4150-87CE-A32B7D9AD42F Q36010745-E3B352A8-90CC-484B-A467-8FE398EDA455 Q36213431-5D5AAE3E-70CF-4605-97C8-98B3D61F4EE1 Q36650385-55188934-3DFF-42FE-BCB3-C3361700DAE1 Q36771076-609F53AE-8760-4FA0-B2E0-B72761ABFEFA Q36917961-C521E6C7-9CEE-4317-A9BF-2DD486BEFC90 Q37036482-1DF9E2E3-A26D-4FA0-A5CD-BAAF59896EFE Q37102970-CC4B620A-F027-499A-9BEA-1948824C1D3A Q37104201-F7329859-00E4-41B3-97C2-3FF073183514 Q37107151-8A27AFF6-735E-4DDF-98EB-D07E0AC7305A Q37254863-5FD09AA5-82ED-493F-ADD4-009587924CEB Q37273984-9C52E24B-BE94-4613-BAA6-21D3C893B702 Q37305045-21580403-8CDE-4B24-928B-C1AF40A41B92 Q37677602-31DBE959-033F-496A-A0F8-9585C4E822FB Q37781118-5C77C456-8759-4DF5-B5FF-1E3D5306DFD4 Q37809460-49834FC0-06DE-4AF7-9A99-4FD563673542 Q37831796-B7147D36-94C8-4FC4-A26A-99D1AC25FE59 Q38177370-76AF32A3-0889-4F68-8833-2B81122876B3 Q38195828-BBAD2195-1D4B-4A4A-8CB9-897785CBFA97 Q38364218-EDBDC537-D99D-43AF-BCEB-AE2058A0B4A5 Q38525935-8A252A13-0903-4755-BC92-699CFBA17132

P2860

Species- and cell type-specific interactions between CD47 and human SIRPalpha.

http://www.wikidata.org/entity/Q42064991

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Species- and cell type-specific interactions between CD47 and human SIRPalpha.

@en

Species- and cell type-specific interactions between CD47 and human SIRPalpha.

@nl

type

label

Species- and cell type-specific interactions between CD47 and human SIRPalpha.

@en

Species- and cell type-specific interactions between CD47 and human SIRPalpha.

@nl

prefLabel

Species- and cell type-specific interactions between CD47 and human SIRPalpha.

@en

Species- and cell type-specific interactions between CD47 and human SIRPalpha.

@nl

P1433

Q42064991-0D0F4FFE-E7D0-417A-8953-DD6A73335137

P1476

Q42064991-C066B5CD-00F6-45DB-A28F-E88D0C464ABF

P2093

Q42064991-0963C134-74B3-4C03-8CAA-1D785DA6DD80

Q42064991-39C1C0E6-FCED-4EEB-80EC-1A4585353211

Q42064991-F416E296-533B-4E6E-ABE5-D0B0B9F4D7FF

P2860

Q42064991-03C64960-CC57-4E6A-86BA-0015171F4E94

Q42064991-05892C02-750B-4DEA-BA3E-0F0B983D0D0A

Q42064991-069773D6-1E09-43C6-A695-F1E11B6890C2

Q42064991-09BAC730-01A8-488B-AF69-2F9A7BC0F8A5

Q42064991-12DABE52-B8A2-4191-B3D6-D39C71C25DF7

Q42064991-1B487318-1D5D-41E0-9729-114689889F2C

Q42064991-224C16D0-7CBE-4A53-A24E-A420136312AA

Q42064991-225633F8-C227-4000-8286-DB2744E8D12B

Q42064991-2624F98A-075E-44EC-B0CC-FC42BFE73004

Q42064991-2D433E0A-524A-4B1D-B9C6-C11D5DDCD691

P304

Q42064991-78777931-4D9B-46B4-BA76-A02C5DE167F0

P31

Q42064991-ABE4D0F0-DFE5-4BF2-A250-5B8EF6965210

P356

Q42064991-F2D8C47E-98ED-4637-8D45-6D221F4A767B

P407

Q42064991-118DF6CF-8F62-4B10-9A6C-5F1E9463232A

P433

Q42064991-04317475-EBE0-410A-917F-3A12343C39F7

P478

Q42064991-A47F2FD6-D534-46A8-8093-B225C6D128D6

P50

Q42064991-241C373C-9129-43DC-8D20-FA40CA808622

Q42064991-A032E0D1-B02B-46A2-BEBD-747CD9C9A18F

P577

Q42064991-88A129DC-245C-48B3-9DE9-359A7CDC1FDC

P5875

Q42064991-7561F91D-6B80-4B37-8970-35AF3379339B

P698

Q42064991-9F2A75FB-FFD6-410C-A8DC-6FA1B734C5CD

P932

Q42064991-0A8ED783-77BB-49CE-9A26-F76BB063FC64

P356

BLOOD-2005-04-1463

P1433

P1476

Species- and cell type-specific interactions between CD47 and human SIRPalpha

@en

P2093

Eric T Boder

http://www.w3.org/2001/XMLSchema#string

Ranganath Parthasarathy

http://www.w3.org/2001/XMLSchema#string

Shyamsundar Subramanian

http://www.w3.org/2001/XMLSchema#string

P2860

Multilineage potential of adult human mesenchymal stem cells

Role of CD47 as a marker of self on red blood cells

Human signal-regulatory protein is expressed on normal, but not on subsets of leukemic myeloid cells and mediates cellular adhesion involving its counterreceptor CD47

Fractional attachment of CD47 (IAP) to the erythrocyte cytoskeleton and visual colocalization with Rh protein complexes

Bidirectional negative regulation of human T and dendritic cells by CD47 and its cognate receptor signal-regulator protein-alpha: down-regulation of IL-12 responsiveness and inhibition of dendritic cell activation

High expression of inhibitory receptor SHPS-1 and its association with protein-tyrosine phosphatase SHP-1 in macrophages

Integrin-associated protein is a ligand for the P84 neural adhesion molecule

Tethering of apoptotic cells to phagocytes through binding of CD47 to Src homology 2 domain-bearing protein tyrosine phosphatase substrate-1

Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis

Visualization of a functionally enhanced GFP-tagged galanin R2 receptor in PC12 cells: constitutive and ligand-induced internalization

P304

2548-2556

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2005-04-1463

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7476147

http://www.w3.org/2001/XMLSchema#string

P698

16291597

http://www.w3.org/2001/XMLSchema#string

P932

1895743

http://www.w3.org/2001/XMLSchema#string